Senti Biosciences

SNTI · NASDAQ

$0.2277+$0.0009 (+0.40%)TodayMarket closed ·
Prev close $0.2268

Who owns SNTI

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 65.8% of SNTI’s shares.

  • Celadon Partners SPV 2431.4%
  • New Enterprise Associates (NEA)12.1%
  • Bayer HealthCare LLC9.0%
  • PharmaEssentia Corp.6.8%
  • Next 6 largest institutions6.5%
  • All other shareholders34.2%
Top institutional holders of SNTI
HolderShares% of shares
Celadon Partners SPV 249.78M31.40%
New Enterprise Associates (NEA)3.78M12.12%
Bayer HealthCare LLC2.81M9.02%
PharmaEssentia Corp.2.11M6.78%
Nantahala Capital Management, LLC888.00K2.85%
Vanguard Capital Management, LLC537.50K1.73%
Geode Capital Management, L.L.C.187.06K0.60%
Lu (Timothy K M.D., Ph.D.)161.63K0.52%
Abante Asesores Gestión, S.G.I.I.C., S.A.132.37K0.43%
Citadel Advisors LLC107.10K0.34%

Largest mutual fund holders

Top mutual fund holders of SNTI
HolderShares% of shares
Vanguard Total Stock Market Index Fund368.88K1.18%
Vanguard Extended Market Index Fund168.63K0.54%
Abante Quant Value, FI132.37K0.43%
Fidelity Extended Market Index Fund95.55K0.31%
Fidelity NASDAQ Composite Index Fund24.80K0.08%

Short interest

Settled Sep 30, 2026

Shares short
487.17K
Days to cover
1.00
% of shares outstanding
1.56%
Average daily volume
1.93M
Change since last report
−4.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.